Evidence map›Paper›PMID 42754164›Full record

ArticleThe Journal of biological chemistry2026

A green-fluorogenic, cysteine-reactive dye enables thermal shift-based high-throughput screening with membrane proteins.

Anselm F L Schneider, Michelle Keifler, Yung-Ning Chang, Jörg Weiske, Vera Pütter

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anselm F L SchneiderNuvisan ICB GmbH, Lead Discovery Berlin, Protein Technologies, Berlin, Germany.
Michelle KeiflerNuvisan ICB GmbH, Lead Discovery Berlin, Protein Technologies, Berlin, Germany.
Yung-Ning ChangNuvisan ICB GmbH, Lead Discovery Berlin, Protein Technologies, Berlin, Germany.
Jörg WeiskeNuvisan ICB GmbH, Lead Discovery Berlin, Protein Technologies, Berlin, Germany.
Vera PütterNuvisan ICB GmbH, Lead Discovery Berlin, Protein Technologies, Berlin, Germany. Electronic address: Vera.Puetter@nuvisan.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thermal shift assays are useful tools in the biophysical screening of protein targets. They require little assay establishment and no tool compounds, making them particularly useful for proteins with no known natural ligands. Their use in compound-screening is typically limited to soluble proteins, however, as membrane proteins that are solubilized in detergent cannot be routinely used with the fluorogenic dyes that detect hydrophobic surfaces upon protein unfolding. As an alternative, a method has been described that utilizes the frequent occurrence of cysteines within the transmembrane region of membrane proteins in combination with fluorogenic, cysteine-reactive dyes to record melting curves of membrane proteins. Here, we evaluate several novel candidate dyes and find that the dye Naph-EA-Mal can reliably record melting points of membrane proteins at low concentrations and with high tolerance for different buffers or classes of membrane proteins. We apply the thermal shift assay with the new dye to a buffer optimization for the ion channel GIRK4 and to a fragment screen with the solute carrier Spns2. Thereby, we discover a new binder scaffold that may be useful in the development of Spns2 inhibitors in the future.

Indexed as

A2ARbeta2ARbinder screenbiophysicsGPCRG proteinactivated inward rectifier potassium channel 4Ion chanelMembrane proteinsSphingosine-1-phosphate transporter SPNS2thermal shift assaytransporter

Identifiers

PMID42754164
PMCPMC13681967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.